APP and Alzheimer disease: Experimental models of AD showed that low-number Aβ oligomers obtained intracellularly from APP-expressing cultured cell lines, disrupt hippocampal LTP in brain slices and in vivo, impair memory of complex learned behavior in rats, and decrease dendritic spine density in organotypic hippocampal slice cultures [177].